Bruker Daltonics Announces Further Enhanced TOF/TOF Performance.Business/Technology Editors & Health/Medical Writers BIOWIRE2K ORLANDO, Fla.--(BW HealthWire)--June 3, 2002 At the American Society for Mass Spectrometry The American Society for Mass Spectrometry is a professional association based in the United States that supports the scientific field of mass spectrometry. As of 2007, the society had approximately 7000 members primarily from the US, but also from around the world. conference, Bruker Daltonics Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BDAL BDAL Battle Doll Angelic Layer (game) ) today announced further enhancements to its ultraflex(TM) TOF/TOF high-throughput mass spectrometry system. The ultraflex TOF/TOF is part of the Proteineer(TM) suite, combining automated sample preparation, mass spectrometry and bioinformatics for proteomics. An increased 50 Hz laser repetition rate is now available which in combination with our unique gridless ion optics design and patented AnchorChip(TM) technology provides unsurpassed sensitivity per unit time, making the ultraflex the premier TOF/TOF system for proteomics. New advanced Auto-MS/MS features in the ultraflex TOF/TOF acquisition software improve the workflow, and allow for even higher productivity for any proteomics project. The ultraflex TOF/TOF benefits from Bruker Daltonics' leadership in high-throughput MALDI-TOF MALDI-TOF Matrix Assisted Laser Desorption Ionization - Time of Flight technology aimed at industrial biology. Our MALDI MALDI Matrix-Assisted Laser Desorption/Ionization sample targets have industry-standard microtitre plate (MTP) format, and are thus easily compatible with standard sample preparation robots. An optional robot is now available for automated delivery of additional MTP AnchorChip targets into the ultraflex TOF/TOF for unattended 24/7 operation. ABOUT BRUKER DALTONICS Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information about Bruker Daltonics, please visit www.bdal.com CAUTIONARY STATEMENT Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to technological approaches, product development, manufacturing, market acceptance, cost and pricing of Bruker Daltonics' products, dependence on collaborative partners, suppliers, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. and other risk factors discussed from time to time in Bruker Daltonics' reports or filings with the Securities and Exchange Commission. Bruker Daltonics expressly disclaims any obligation to update the information contained herein. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion